In 1986, European Directive 86/609/EEC, regulating the use of animals in research, was one of the first examples of common legislation to set standards for animal protection across the Member States of the former European Economic Community (EEC), now the European Union (EU), with the aim of securing a level European playing field. Starting in 2002, a process of revising European animal experimentation legislation was undertaken with one of its key aims being to ensure high standards of welfare for laboratory animals across Europe. This resulted in Directive 2010/63/EU, which has regulated this activity in Europe since 2013. Since this is an EU Directive, transposition into national legislation is a necessary and important part of the implementation of the new legislation. This paper gives an overview of the transposition process followed by an analysis of the potential to reach the different objectives of the Directive, particularly with a focus on securing the same high standards of animal protection across member countries. The analysis focuses on three separate issues: (a) minimum standards for laboratory animal housing and care, (b) restrictions on the use of certain animal species and (c) project review and authorization.
Introduction
Europe has a long history of animal protection legislation; the first national legislation in the world to regulate the use of research animals was developed in a European country (Orlans 2002) . In 1986, European Directive 86/609/EEC, regulating the use of animals in research (Council of the European Communities 1986), was one of the first examples of common legislation to set standards for animal protection across the Member States of the former European Economic Community (EEC), now the European Union (EU). This Directive became the entire basis for legislation in some European Member States, whereas other countries developed more extensive and far-reaching national legislation, resulting in substantial differences across European countries regarding the conditions for research and the protection for animals.
Starting in 2002, a process of revising European animal experimentation legislation was undertaken, resulting in Directive 2010/63/EU (European Union 2010). This revision aimed to "strengthen the protection of animals still used in scientific procedures (...) and ensure a level playing field throughout the EU for industry and the research community" (European Commission 2008) . In this paper, we aim to present and discuss the development of recent European legislation regarding animal experimentation with a focus on how far the revised legislation has succeeded in eliminating disparities between countries and how the tension between the different aims of the revision can be handled in actual practice.
We begin with an overview of the political and administrative process of revising and implementing this legislation and with the changes that the revision introduced. We then focus on three different issues regulated by the Directive: minimum standards for housing and care, restrictions on the use of different animal species and project review for authorization. Finally, we discuss to which extend regarding these issues the aims of the Directive can be said to have been achieved by the Directive.
From Directive 86/609/EEC to Directive 2010/63/EU European Legislation Regulating Animal Experimentation From 1986 to 2010
Two Europe-wide legal instruments regulating the use of animals in research came into effect in 1986 (for an overview of European governance, see Table 1 ). The first of these was the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (ETS123), published by the Council of Europe (Council of Europe 1986) . With the primary aim of reducing the number of animals used in research and encouraging signing parties to use animals only where alternatives do not exist, this document laid down general principles for when and how experiments with animals were to be carried out, and also provided technical details on how to house animals. Later in the year, the European Economic Community (now the European Union) published Directive 86/609/EEC. The Convention and the Directive overlap considerably in content, but are two different documents and have different legal status. Conventions are only legally binding to the parties which ratify them, whereas directives must be implemented by all Member States. The functioning of the former European Communities per definition limited the scope of Directive 86/609/EEC to areas of economic activity (thus excluding animal use within academic research and teaching, see (European Parliament 2002) p11), whereas Convention ETS123 covered all uses of animals for experimental and other scientific purposes. This discrepancy was partly overcome in 1999 when the European Union became party to Convention ETS123 ((European Union 1999).
Directive 86/609/EEC remained in place with no plans for changes until 2002 when the revision process was initiated. During these more than 15 years, considerable technical and scientific progress was made, and significant changes had also affected the political and legislative context. The European Economic Community had become the European Union with a wider political mandate. Legislation going beyond mere economic activity was seen as necessary to harmonise Member State Law to facilitate the functioning of the Single Market (Treaty on the Functioning of the European Union, Article 114). Any obstacles to the free movement of people, goods, services and capital were increasingly addressed through Directives and Regulations; the interpretation of the single market was broad, covering a wide range of activities relating to the economy. This included the strengthening of the European Research Area.
An important driver in the legislation on animal use for scientific purposes concerns ensuring that no Member State derives an advantage over another by allowing weaker standards than the agreed minimum when it comes to protecting animal welfare. Animal welfare has gained a stronger status with the mandate of political as well as economic integration that has come with the formation of the European Union (Table 1) . This strengthening was first established in 1997 through a protocol annexed to the Treaty of Amsterdam requiring that animal welfare was to be considered in the development of European legislation (European Union 1997). Thus, when revision started in 2002, the 1986 Directive was seen as unsuccessful in creating an adequate minimum standard because the regulation of animal experimentation had become very uneven across the EU as a result of the fact that some Member States had more extensive national legislation while others had merely transposed the 1986 Directive.
The revision was requested by the European Parliament, explicitly motivated by the changes in science and in public attitudes that had occurred since Directive 86/609/EEC came into force; specifically, it was motivated by the limited coverage excluding animals in education and basic research, by the differing standards between countries and by insufficient attention to the 3Rs and animal welfare. The Parliament furthermore argued that given increased public concern over animal welfare, it was inappropriate that legislation protecting experimental animals would have "as its original basis, not the welfare of such animals, but undistorted trade between Member States" (European Parliament 2002). In asking for animal welfare to be given stronger status within this legislation, the European Parliament, which is the only directly democratically elected body of the key EU institutions, also politically challenged the moral basis for the previous legislation.
The revision process was initiated through the establishment of a Technical Expert Working Group (TEWG), which brought together national authorities as well as stakeholder organizations to provide scientific and technical advice in response to specific questions raised by the European Commission. The response was published in 2003 in final reports of the four respective subgroups on 1) Scope; 2) Authorization; 3) Ethical review and 4) Cost-benefit (European Commission 2003) . The Commission further sought scientific expert input in regard to animal sentience, origin of experimental animals and euthanasia methods (European Food Safety Authority: Scientific Panel on Animal Health and Welfare 2005). The TEWG work was followed by a period of internal Commission consultation and drafting leading up to the presentation of the first draft proposal in the autumn of 2008.
The scientific community, industry and NGOs followed the revision process closely. During the revision period, hearings were organized and policy briefings and statements published by several important European research organizations. The first public draft version of the revised Directive was met with considerable criticism by the research community, which feared limitations to research which they argued would interfere with the possibilities for scientists and industry to operate within the European Research Area (e.g. (FELASA 2007) (Anonymous 2008) ). This debate was coupled with an intense political battle over the new draft version of the Directive in the European Institutions (European Parliament Legislative Observatory 2010). The turbulent process leading up to the finally accepted Directive agreed upon by the European Commission, the European Parliament and the European Council on 7 April, 2010 was aptly described by the scientific journal Nature as "more than a decade of pitched battles between research advocates and animal-rights campaigners" (Abbott 2010) .
Directive 2010/63/EU introduces substantial changes compared to 86/609/EEC. Setting the standard according to the most extensive and demanding national legislations may not have been explicitly established as the goal for the revision, but considering the aim to provide a level playing field, and the political impossibility of lowering standards in countries where extensive national legislation was in place, it was an unavoidable outcome. In his comparative analysis of the 1986 and the 2010 Directives, Thomas Hartung concluded that little would change for the countries with more demanding legislation, whereas for countries where legislation had been based mainly on Directive 86/609/EEC, a number of new demands would arise. Some of the most important features introduced by Directive 2010/63/EU are extended scope, enhanced focus on the 3Rs and alternative methods, mandatory project evaluation, severity classification and retrospective assessment, institutional animal welfare bodies as well as revised guidelines for accommodation and care, which are now mandatory. For a detailed, article by article, comparison of the two Directives, the reader is referred to Hartung (2010) and for a general overview of European legislation regulating animal research to (Guillen and others 2014). 
Directive 2010/63/EU and Its Transposition
Since the legislation is by way of a Directive, transposition into national legislation is an important part of the implementation of the new law. Whereas an EU Regulation applies directly into member state law, a Directive must be 'transposed' -implemented -into member state law within a defined timescale to gain its effect. This generally gives some space for Member State discretion in the implementation: the Directive must be implemented into Member States' domestic Law, but first, there is formal discretion as a Directive will contain specific choices that a Member State can take, under specific conditions (perhaps requiring alternative safeguards), or second, because the act of transposition requires an interpretation of the language of the Directive's text, and that is essentially a political act. Therefore, whereas the aim of a Directive is harmonisation, there are limits to the level of harmonisation that can be achieved compared to the direct effect of a Regulation (that does not require the transposition). It is the role of the European Commission and the Court of Justice of the European Union (ECJ) to ensure that those differences resulting from the various ways of applying these discretions are not too wide to prevent the intended harmonisation.
Directive 2010/63/EU entered into force in the autumn of 2010 and required Member States to transpose it into national legislation by 1 January 2013. Transposition progressed at a very different pace within the different Member States. Only a minority complied within the deadline; most countries completed transposition during 2013. In two cases -The Netherlands and Italy -delays in transposing the Directive led to the European Commission referring the countries to the European Court of Justice for failure to enact EU legislation; however both countries eventually completed the transposition.
To help Member States in the implementation and to ensure a common understanding, the European Commission produced a number of guidance documents. These include a 'Questions and Answers' document on the legal understanding, and a series of guidance documents on different aspects of the Directive. These guidance documents were produced by expert working groups with representatives from different stakeholder organizations (e.g. industry, academia, NGOs, professional organizations) at meetings in Brussels, and the resulting documents were thereafter endorsed by the National Contact Points, i.e. the person in each Member State responsible for the implementation of the Directive. A list of the different aspects covered and a brief description of the content of the guidance documents is presented in Table 2 . The content of the documents corresponds well to the most important new demands introduced by Directive 2010/63/EU, but does not give an exhaustive picture of the changes. Table 2 . The different aspects covered in guidance produced by expert working groups under the European Commission to support implementation of the Directive. Each of these topics corresponds to one (two for Severity assessment) guidance document available at http://ec.europa.eu/environment/chemicals/lab_animals/interpretation_en.htm.
Animal Welfare Bodies and National Committees: Guidance and principles of good practise on the design and functioning of Animal Welfare Bodies and National Committees for the protection of animals used for scientific purposes Education and training: Education and training framework with a modular Learning Outcomebased training structure, principles and criteria for supervision, competence assessment, continued professional development and a mutual approval and accreditation of courses Genetically altered animals: The principles of creation, establishment and maintenance of genetically altered animal lines and how these are considered within project authorisation and statistical reporting Inspections and enforcement: Guidance and principles of good practice on the planning and execution of an effective inspection and enforcement programme Non-technical project summaries: Guidance on the drafting and publication of non-technical project summaries including a template and an illustrative example Project Evaluation/Retrospective Assessment: Guidance for performance of Project Evaluation including harm-benefit assessment and Retrospective Assessment of projects Severity assessment: The severity assessment framework from project planning, monitoring and assessing the severity through to final assignment of actual severity. Severity assessmentillustrative examples Other: Practices that are exempted from the scope; understanding of definitions for a procedure and project; use, re-use and continued use; multiple generic projects and complex or multi-disciplinary projects Some transnational infrastructures have also being created to support implementation. Several of these have been instituted by the European Commission, whereas others were initiatives born out of practitioners' perceived need to network. The European Education and Training Platform in Laboratory Animal Science facilitates exchange of information on laboratory animal science education and training provided in different countries and by different providers in order to promote mutual recognition of training courses between countries. The PARERE Network (Preliminary Assessment of Regulatory Relevance) serves as the "single point of contact to provide advice on the regulatory relevance and suitability of alternative approaches proposed for validation." (Article 47). There is an on-going discussion of the need for networks of animal welfare bodies and of animal ethics committees.
Directive 2010/63/EU goes beyond the general requirements for transposition of EU directives by also explicitly hindering Member States from developing national measures which are more restrictive than those set in the Directive. A Member State is only allowed to maintain more restrictive national measures provided these were in force in November, 2010 and the European Commission had been informed before 1 January, 2013. In 2016 the European Commission initiated an infringement process against Italy for imposing greater restrictions on animal research than what is mandated by the Directive (European Animal Research Association 2016).
Directive 2010/63/EU -Harmonization and Room for Interpretation
Directive 2010/63/EU is organized into three main sections: 56 Recitals, 66 Articles and seven Annexes. The Recitals form a structured narrative text which presents the reasons for the legal act and guidance for the implementation of the Articles, whereas the Articles and the Annexes, which complement them, provide the actual norms or rules introduced by the act. The Articles are organized into six chapters. Chapter I, General provisions, establishes the situations in which the Directive applies and for what purposes animals can be used, defines key terms, and establishes the 3Rs principle as the guidance for animal experimentation. Chapter II, Provision on the use of certain animals for procedures, establishes the limitations for the use of endangered species, non-human primates, animals taken from the wild and stray and feral animals of domestic species and defines purpose-bred animals as the standard approach for animals of the typical laboratory species. Chapter III, Procedures, includes more specific provisions for implementing the 3Rs through methods, anaesthesia, severity classification, reuse of animals, endpoints, sharing organs and tissues and rehoming animals. Chapter IV, Authorization, establishes requirements for breeders, suppliers and users of animals in terms of conditions of care, responsibilities and training of personnel and advisory bodies. It further addresses inspections and requirements for project evaluation and authorization. Chapter V, Avoidance of duplication and alternative approaches, focuses on the recognition and development of non-animal alternatives and Chapter VI, Final provisions sets the rules for implementation, adaptation, reporting and the role of different entities. Finally, the seven annexes provide more detailed information complementing some of the articles. The new Directive is in many respects a significant development from previous law. It is comprehensive, in as much as it seeks to regulate all aspects of the use of animals in scientific experiments. Thus, it has an increased scope in terms of the types of animals (now including not only vertebrates but also cephalopods and later fetal and larval stages of vertebrate animals) and the forms of animal use that are covered (research, testing and teaching). Furthermore, it regulates (primarily through licensing) each aspect of the chain of animal involvement: the breeding of animals for use in science, the scientists engaged in research and testing, those who have welfare responsibilities for the animals during that period, and the institutions in which research takes place.
Thus, on the face of it, the new Directive produces a high degree of structural harmonization. Whether this is translated into harmonized practice depends upon how much underlying room for interpretation there is. In the following, we will look at three different issues which, as we will see, represent three different degrees of harmonization potential in practice: minimum standards for housing and care, restrictions on the use of different animal species and project evaluation and authorization.
Minimum Standards for Laboratory Animal Housing and Care
The standards for housing and caring for laboratory animals are laid down in Annex III of the Directive: Requirements for establishments and for the care and accommodation of animals. This approach, with an annex to the main text containing extensive technical detail, is the same as was used for Directive 86/609/EEC as well as for the European Convention ETS123. In fact, the standards used in the present Directive come from the revised version of the ETS123 Appendix A.
This text has been undergoing a very thorough revision since 1998. The revised version, published in 2006, was the result of more than five years of work of more than 50 experts on animal behavior, health and welfare. In addition to revising the existing technical standards, standards for a number of less common but still important animal species groups were developed. The standards now include rodents, rabbits, cats, dogs, ferrets, non-human primates, birds, reptiles and amphibians. Annex III has a section which addresses general aspects of the oorganization of the animal facility (functions, general design and rooms of different types), environmental control (climate, lighting, noise and alarm systems) and animal care (health, housing environment, feeding/watering and handling). This is followed by a species-specific section that provides technical details and measures for minimum space requirements for animal enclosures of different species. Whereas Annex III is based on the ETS123 Appendix A, it incorporates only the engineering standards, thus leaving out the performance standards of Appendix A.
In the Directive itself, there is reference to Annex III in Articles 22 (Requirement for installations and equipment) and 33 (Care and accommodation). Article 22 requires that the standard set in Annex III is complied with in order for establishments to "have installations and equipment suited to the species of animals housed" and allows no exemption. Article 33, on the other hand, allows exemptions from Annex III "for scientific, animal-welfare or animal-health reasons".
All in all, this part of the Directive sets a very clear minimum standard, for which there is little room for exemptions. That Article 22 does not allow exemptions means that an establishment must definitely have the capacity to comply with Annex III. The exemptions in Article 33 most likely only cover individual experiments or management situations, as it is unlikely that a justifiable reason can be presented for general exemptions from the minimum housing and care requirements defined in Annex III. Here, there is a potential for a high degree of harmonisation.
Restrictions on the Use of Certain Animal Species
In a number of Articles, the Directive restricts the use of particular animals: animals of endangered species, non-human primates, animals taken from the wild and stray/feral animals of domestic species. Each of these Articles starts by stating that animals of the type in question "shall not be used in procedures". However, for each case, there are also a number of foreseen exemptions, as illustrated in Table 3 . In all cases except for great apes, the foreseen exemptions are listed immediately after the statement that these animals shall not be used in procedures. For endangered species and nonhuman primates which are not great apes, the only limitation, in effect, is that the use of these animals may only be accepted for certain research purposes (see Table 3 for which purposes are allowed and for which species). The strongest restriction is on great apes: their use requires activation of the general safeguard clause Article 55. This permits a Member State to provisionally allow otherwise banned experiments if essential "for the preservation of the species or in relation to an unexpected outbreak of a life-threatening or debilitating clinical condition in human beings". In terms of harmonisation, and strong animal welfare, the Directive appears very strong regarding the restriction of the use of particular animals. This creates a presumption that such animals should not be used, but there is still no absolute restriction. This opens the possibility for different interpretations at the national level -in fact, it explicitly gives competent authorities and Member States authority to determine when the conditions for exemptions are fulfilled. Thereby, room is created for different interpretations of what is required for exemption to the general rule. Competent authorities may grant exemptions only if a) there is an essential need to study the health and welfare of the animals or serious threats to the environment or human or animal health and b) there is scientific justification that the purpose can be achieved only by using a stray or feral animal -
Project Evaluation and Authorization
The framework for evaluating and authorizing projects is an aspect which is substantially affected by the transposition of the Directive, in that an evaluation and subsequent authorization is now required before any experiment with animals is initiated. Furthermore, Member States are required to set up a competent authority to regulate and administer the evaluation and authorization of projects involving animal experiments.
As shown in Table 4 , the Directive defines a number of criteria that should be satisfied for authorization to take place -articles 36, 37 and 38 establish the requirement for authorization, the information which should be provided in applications and the aspects and expertise to be considered in evaluation -but the specific way in which authorization process is organized is not defined. In fact, Article 59 opens for the delegation of different tasks (including project authorization) to bodies other than the competent authority. The way project authorizations are handled plays a crucial regulatory role in that this is the mechanism which determines what research can take place and under what conditions. This is the reason why, in the ANIMPACT project, on which the present paper is largely based, we have mapped the systems for project evaluation and authorization across the EU in detail. Article 38 -Project evaluation 1. The project evaluation shall be performed with a degree of detail appropriate for the type of project and shall verify that the project meets the following criteria: (a) the project is justified from a scientific or educational point of view or required by law; (b) the purposes of the project justify the use of animals; and (c) the project is designed so as to enable procedures to be carried out in the most humane and environmentally sensitive manner possible. 2. The project evaluation shall consist, in particular, of the following:
(a) an evaluation of the objectives of the project, the predicted scientific benefits or educational value; (b) an assessment of the compliance of the project with the requirement of replacement, reduction and refinement; (c) an assessment and assignment of the classification of the severity of procedures; (d) a harm-benefit analysis of the project to assess whether the harm to the animals in terms of suffering, pain and distress is justified by the expected outcome taking into account ethical considerations, and may ultimately benefit human beings, animals or the environment; (e) an assessment of any justification [required for a number of predefined exceptions]; and (f) a determination as to whether and when the project should be assessed retrospectively. 3. The competent authority carrying out the project evaluation shall consider expertise, in particular, in the following areas: (a) the areas of scientific use for which animals will be used including replacement, reduction and refinement in the respective areas; (b) experimental design, including statistics where appropriate; (c) veterinary practice in laboratory animal science or wildlife veterinary practice where appropriate; (d) animal husbandry and care, in relation to the species that are intended to be used. 4. The project evaluation process shall be transparent. Subject to safeguarding intellectual property and confidential information, the project evaluation shall be performed in an impartial manner and may integrate the opinion of independent parties
When Directive 2010/63/EU entered into force, most if not all European Member States 1 already had a system in place for evaluating and authorizing animal experiments. As can be 2 seen in Table 4 , the Directive gives detailed guidelines on what is to be covered in the 3 evaluation, whereas it does not specify how it should be undertaken, e.g. regarding the 4 composition of reviewing body and regarding on what level the evaluation is to take place.
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As a result, the regulation is sufficiently general on project evaluation to allow an array of 6 rather diverse previously established systems to continue to operate. Based on the 7 information we have collected from Member State competent authorities (Silva and others 8 2015), it is evident that there is considerable diversity between Member States as regards the 9 approach to evaluation and authorization, in terms of administrative/geographical 10 organization as well as committee composition and expertise.
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The geographic or administrative level organization includes a range of approaches: national,
12
regional and institutional evaluation committees as well as combinations of these, as 13 illustrated in Figure 1 . 
41
How the variation in composition will affect the variation in outcome is not yet known -and it
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will not be simple to evaluate. But, it is known from an experimental study from the USA that 
50
proposed framework has no legal status and is less than clear on a number of points.
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Thus the "harm-benefit analysis of a project, to assess whether the harm to the animals in 
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The comparatively strong support this represents is clear when considering that since the gather the required number of signatures (a million citizens in total and a minimum number of signatories in at least seven EU countries) to be received by the EC. However, the direct 70 political consequences were minor or negligible.
In response, the European Commission clearly stated that the ultimate aim is full replacement
72
of animal experiments but that this is presently not possible and that "a premature ban of 73 research using animals in the EU would likely export the biomedical research and testing
74
outside the EU to countries where welfare standards may be lower and more animals may be 75 needed to achieve the same scientific results"(European Commission 2015).
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The Commission further committed itself to actions to "accelerate the development and 77 uptake of non-animal approaches in research and testing". However, these actions were 78 presented in general terms rather than as measurable concrete activities.
79
Various mechanisms are in place to monitor how well the Directive and its implementation 
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The present paper is the first to be published from the project. 
